C12Q2527/107

Fast PCR for STR genotyping

Disclosed is a method of amplifying a nucleic acid sequence, wherein the method comprises subjecting a reaction mixture to at least one amplification cycle, wherein the reaction mixture comprises a double-stranded nucleic acid and at least two primers capable of annealing to complementary strands of the double-stranded nucleic acid and amplifying at least one short tandem repeat (STR) using a Family A DNA polymerase in a Fast PCR protocol having a two-step amplification cycle in 25 seconds or less. Also disclosed are real-time PCR methods using the two-step protocol and kits for STR profiling using the Fast PCR protocol.

IN-SITU CONCATENATION OF OLIGO-NUCLEOTIDE PROBES FOR TARGET DETECTION
20220315994 · 2022-10-06 · ·

The present invention relates to a multiplicity of nucleic acid probes, a composition comprising said probes and uses thereof. The invention relates to a multiplicity of non-beacon, hairpin loop forming nucleic acid probes. In particular, the invention relates to a multiplicity of nucleic acid probes, each nucleic acid probe comprising a nucleic acid sequence complementary to the target nucleic acid sequence; wherein said nucleic acid probes are capable of forming a multimer in-situ with at least a neighbouring probe. The invention relates to the use of nucleic acid probes to detect the presence or absence of organisms in biological samples.

IN-SITU CONCATENATION OF OLIGO-NUCLEOTIDE PROBES FOR TARGET DETECTION
20220315994 · 2022-10-06 · ·

The present invention relates to a multiplicity of nucleic acid probes, a composition comprising said probes and uses thereof. The invention relates to a multiplicity of non-beacon, hairpin loop forming nucleic acid probes. In particular, the invention relates to a multiplicity of nucleic acid probes, each nucleic acid probe comprising a nucleic acid sequence complementary to the target nucleic acid sequence; wherein said nucleic acid probes are capable of forming a multimer in-situ with at least a neighbouring probe. The invention relates to the use of nucleic acid probes to detect the presence or absence of organisms in biological samples.

Rapid Quantitative Detection of Single Nucleotide Polymorphisms or Somatic Variants and Methods to Identify Malignant Neoplasms

Provided are systems, kits, and methods for the quantitative detection of single nucleotide polymorphisms or variants to identify malignant neoplasms. The methods include use of modified oligonucleotide blockers with peptide nucleic acid backbones that hybridize to and block logarithmic amplification of the wild-type alleles of a target, and incorporation of locked nucleic acids into probes that are complementary to a mutant allele of the target sequence to increase specificity. The methods include detection of variants in sequences with high GC content and/or low complexity, such as the TERT promoter, IDH1, BRAF, NRAS, GNAQ, GNA11 and H3F3 A gene variants. The methods include sensitive detection and staging of cancers with low cellularity, and can be used intraoperatively such as for glioma, or to detect cell-free circulating tumor DNA, such as for melanoma.

Rapid Quantitative Detection of Single Nucleotide Polymorphisms or Somatic Variants and Methods to Identify Malignant Neoplasms

Provided are systems, kits, and methods for the quantitative detection of single nucleotide polymorphisms or variants to identify malignant neoplasms. The methods include use of modified oligonucleotide blockers with peptide nucleic acid backbones that hybridize to and block logarithmic amplification of the wild-type alleles of a target, and incorporation of locked nucleic acids into probes that are complementary to a mutant allele of the target sequence to increase specificity. The methods include detection of variants in sequences with high GC content and/or low complexity, such as the TERT promoter, IDH1, BRAF, NRAS, GNAQ, GNA11 and H3F3 A gene variants. The methods include sensitive detection and staging of cancers with low cellularity, and can be used intraoperatively such as for glioma, or to detect cell-free circulating tumor DNA, such as for melanoma.

SYSTEM AND METHOD FOR MELTING CURVE NORMALIZATION

The present invention relates to methods for the analysis of nucleic acids present in biological samples, and more specifically to normalize a high resolution melt curve to assist in the identification of one or more properties of the nucleic acids. The present invention provides methods and systems that incorporate a background identification algorithm according to invention principles using raw melt curve data to identify reactions that are unrelated actual DNA melt reactions. Furthermore, a web-based application for analyzing experimental data is provided. The raw experimental data obtained from a variety of instruments is processed and analyzed on a server and presented to a user through a user interface (UI).

SYSTEM AND METHOD FOR MELTING CURVE NORMALIZATION

The present invention relates to methods for the analysis of nucleic acids present in biological samples, and more specifically to normalize a high resolution melt curve to assist in the identification of one or more properties of the nucleic acids. The present invention provides methods and systems that incorporate a background identification algorithm according to invention principles using raw melt curve data to identify reactions that are unrelated actual DNA melt reactions. Furthermore, a web-based application for analyzing experimental data is provided. The raw experimental data obtained from a variety of instruments is processed and analyzed on a server and presented to a user through a user interface (UI).

Amplicon melting analysis with saturation dyes

Methods are provided for nucleic acid analysis wherein a target nucleic acid that is at least partially double stranded is mixed with a dsDNA binding dye having a percent saturation of at least 50% to form a mixture. In one embodiment, the nucleic acid is amplified in the presence of the dsDNA binding dye, and in another embodiment a melting curve is generated for the target nucleic acid by measuring fluorescence from the dsDNA binding dye as the mixture is heated. Dyes for use in nucleic acid analysis and methods for making dyes are also provided.

Amplicon melting analysis with saturation dyes

Methods are provided for nucleic acid analysis wherein a target nucleic acid that is at least partially double stranded is mixed with a dsDNA binding dye having a percent saturation of at least 50% to form a mixture. In one embodiment, the nucleic acid is amplified in the presence of the dsDNA binding dye, and in another embodiment a melting curve is generated for the target nucleic acid by measuring fluorescence from the dsDNA binding dye as the mixture is heated. Dyes for use in nucleic acid analysis and methods for making dyes are also provided.

DETECTION OF TARGET NUCLEIC ACID SEQUENCES USING DIFFERENT DETECTION TEMPERATURES AND REFERENCE VALUES
20170362646 · 2017-12-21 ·

The present invention relates to detection of target nucleic acid sequences using different detection temperatures and reference values. The present invention employing different detection temperatures and reference values enables to detect a plurality of target nucleic acid sequences in conventional real-time manners even with a single type of label in a single reaction vessel.